Linezolid pharmacokinetics and pharmacodynamics in clinical treatment.

Article Details

Citation
Copy to clipboard

Dryden MS

Linezolid pharmacokinetics and pharmacodynamics in clinical treatment.

J Antimicrob Chemother. 2011 May;66 Suppl 4:iv7-iv15. doi: 10.1093/jac/dkr072.

PubMed ID
21521707 [ View in PubMed
]
Abstract

Linezolid has been widely used in the treatment of Gram-positive infections for more than a decade. It is unique amongst antibiotics active against most multiply-resistant Gram-positive bacteria in that there is an oral preparation with 100% bioavailability and an extensive volume of distribution. This review examines pharmacokinetic data relating to linezolid use in different patient groups (obesity, enteral feeding, renal failure, neonates, and paediatrics) and in different clinical conditions (sepsis syndrome, skin and soft tissue infection, diabetic foot infection, pneumonia, bone and joint infection, infection of the central nervous system, eye infection, and neutropenic sepsis).

DrugBank Data that Cites this Article

Drugs